13
false
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2023-10-01
Sage Accounts Production Advanced 2024 - FRS102_2024
xbrli:pure
xbrli:shares
iso4217:GBP
12697969
2023-10-01
2025-03-31
12697969
2025-03-31
12697969
2023-09-30
12697969
2022-10-01
2023-09-30
12697969
2023-09-30
12697969
2022-09-30
12697969
core:DevelopmentCostsCapitalisedDevelopmentExpenditure
2023-10-01
2025-03-31
12697969
core:PlantMachinery
2023-10-01
2025-03-31
12697969
bus:LeadAgentIfApplicable
2023-10-01
2025-03-31
12697969
bus:Director4
2023-10-01
2025-03-31
12697969
core:WithinOneYear
2025-03-31
12697969
core:WithinOneYear
2023-09-30
12697969
core:ShareCapital
2025-03-31
12697969
core:ShareCapital
2023-09-30
12697969
core:RetainedEarningsAccumulatedLosses
2025-03-31
12697969
core:RetainedEarningsAccumulatedLosses
2023-09-30
12697969
bus:Director1
2023-10-01
2025-03-31
12697969
bus:SmallEntities
2023-10-01
2025-03-31
12697969
bus:AuditExemptWithAccountantsReport
2023-10-01
2025-03-31
12697969
bus:SmallCompaniesRegimeForAccounts
2023-10-01
2025-03-31
12697969
bus:PrivateLimitedCompanyLtd
2023-10-01
2025-03-31
12697969
bus:AbridgedAccounts
2023-10-01
2025-03-31
12697969
core:ComputerEquipment
2023-10-01
2025-03-31
|
STATEMENT OF CONSENT TO PREPARE ABRIDGED FINANCIAL STATEMENTS |
|
All of the members of GBG Healthcare Limited have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the period ending 31 March 2025 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER:
12697969
|
FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS |
|
|
REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY ABRIDGED FINANCIAL STATEMENTS OF
GBG HEALTHCARE LIMITED |
|
PERIOD FROM 1 OCTOBER 2023 TO 31 MARCH 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of GBG Healthcare Limited for the period ended 31 March 2025, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.
LANGARD LIFFORD HALL LIMITED
Accountants and Registered Auditors
Lifford Hall
Lifford Lane
Kings Norton
Birmingham
B30 3JN
17 December 2025
|
ABRIDGED STATEMENT OF FINANCIAL POSITION |
|
31 March 2025
|
31 Mar 25 |
30 Sep 23 |
|
Note |
£ |
£ |
£ |
£ |
|
|
|
|
|
Fixed assets
|
Intangible assets |
5 |
|
– |
|
827 |
|
Tangible assets |
6 |
|
10,593 |
|
16,166 |
|
|
------------ |
|
------------ |
|
|
10,593 |
|
16,993 |
|
|
|
|
|
|
Current assets
|
Stocks |
143,151 |
|
1,165,104 |
|
|
Debtors |
309,545 |
|
551,487 |
|
|
Cash at bank and in hand |
434,908 |
|
1,275,380 |
|
|
------------ |
|
-------------- |
|
|
887,604 |
|
2,991,971 |
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
1,128,692 |
|
2,532,779 |
|
|
-------------- |
|
-------------- |
|
|
Net current (liabilities)/assets |
|
(
241,088) |
|
459,192 |
|
|
------------ |
|
------------ |
|
Total assets less current liabilities |
|
(
230,495) |
|
476,185 |
|
|
|
|
|
|
Provisions |
|
17,796 |
|
21,838 |
|
|
------------ |
|
------------ |
|
Net (liabilities)/assets |
|
(
248,291) |
|
454,347 |
|
|
------------ |
|
------------ |
|
|
|
|
|
Capital and reserves
|
Called up share capital |
|
10,000 |
|
10,000 |
|
Profit and loss account |
|
(
258,291) |
|
444,347 |
|
|
------------ |
|
------------ |
|
Shareholders (deficit)/funds |
|
(
248,291) |
|
454,347 |
|
|
------------ |
|
------------ |
|
|
|
|
|
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
|
ABRIDGED STATEMENT OF FINANCIAL POSITION (continued) |
|
31 March 2025
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements
.
These abridged financial statements were approved by the
board of directors
and authorised for issue on
17 December 2025
, and are signed on behalf of the board by:
Company registration number:
12697969
|
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS |
|
PERIOD FROM 1 OCTOBER 2023 TO 31 MARCH 2025
1.
General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lifford Hall, Lifford Lane, Kings Norton, Birmingham, B30 3JN.
2.
Statement of Compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting Policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
These accounts have been prepared on the going concern basis following assurances from the directors of their continuing financial support.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax. Revenue is recognised at the point the service is rendered and any income received in advance of the service being rendered is deferred and held within deferred income within the statement of financial position.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
|
Brand costs |
- |
33% straight line |
|
|
|
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
Plant and machinery |
- |
20% straight line |
|
Equipment |
- |
33% straight line |
|
|
|
|
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Stocks
Medical stock and consumables are measured at cost less any provision for slow moving or obsolete items. Cost includes all costs of purchase and other costs incurred in bringing the stock to its present location and condition.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the abridged statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4.
Employee Numbers
The average number of persons employed by the company during the period amounted to
13
(2023:
17
).
5.
Intangible Assets
|
£ |
|
Cost |
|
|
At 1 October 2023 and 31 March 2025 |
2,483 |
|
------------ |
|
Amortisation |
|
|
At 1 October 2023 |
1,656 |
|
Charge for the period |
827 |
|
------------ |
|
At 31 March 2025 |
2,483 |
|
------------ |
|
Carrying amount |
|
|
At 31 March 2025 |
– |
|
------------ |
|
At 30 September 2023 |
827 |
|
------------ |
|
|
6.
Tangible Assets
|
£ |
|
Cost |
|
|
At 1 October 2023 |
42,070 |
|
Additions |
7,402 |
|
------------ |
|
At 31 March 2025 |
49,472 |
|
------------ |
|
Depreciation |
|
|
At 1 October 2023 |
25,904 |
|
Charge for the period |
12,975 |
|
------------ |
|
At 31 March 2025 |
38,879 |
|
------------ |
|
Carrying amount |
|
|
At 31 March 2025 |
10,593 |
|
------------ |
|
At 30 September 2023 |
16,166 |
|
------------ |
|
|
7.
Related Party Transactions
There were no related party transactions during the year that require disclosure.
8.
Parent Undertaking
The company's parent company at the balance sheet date is
Better Health Group Limited
, a company registered in England and Wales whose registered office is Lifford Hall, Lifford Lane, Kings Norton, Birmingham, B30 3JN.